QUICK LINKS
SEE ALSO...
Hep C E2 Antibody (BDI167) is a mouse monoclonal IgG1 antibody that detects Hep C E2 in Hepatitis C virus by western blotting (WB), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). Hep C E2 is a crucial envelope glycoprotein that plays a significant role in viral entry into host cells, specifically hepatocytes, which are the primary target for infection. Hep C E2 interacts with the CD81 receptor on liver cell surfaces, facilitating viral envelope fusion with host cell membranes. This interaction enables viral entry and subsequent replication, making Hep C E2 a key target for therapeutic interventions and vaccine development. Additionally, Hep C E2 undergoes various post-translational modifications, including glycosylation, which are essential for stability, proper folding, and function. These modifications influence receptor interactions and contribute to immune response evasion, highlighting Hep C E2′s importance in Hepatitis C infection pathogenesis. Anti-Hep C E2 antibody (BDI167) serves as an invaluable tool for researchers studying Hepatitis C virus entry mechanisms and developing potential antiviral strategies.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Hep C E2 Antibody (BDI167) | sc-57769 | 100 µg/ml | $322.00 |